Nicoya Lifesciences is launching FastHDX, a hydrogen-deuterium exchange mass spectrometry platform to measure protein ...

Emerging mass spectrometry technologies integrating ion mobility, TIMS–PASEF, and real-time search are enhancing sensitivity, ...

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...

Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni ™ mass spectrometer to enable disease researchers to move beyond canonical protein ...

Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...

New advisors bring decades of industry drug discovery leadership and foundational scientific expertise across Proxima's ...

Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the ...

Explore advances in protein imaging techniques and spatial proteomics. Learn how modern imaging tools reveal protein dynamics and organization in cells.

Nicoya Lifesciences, Inc., a leading provider of advanced biophysical characterization tools for biologics discovery and development, today announced the launch of FastHDX, a new hydrogen-deuterium ...